text.skipToContent text.skipToNavigation
Pharma & Biotech

AoAF – Human Aortic Adventitial Fibroblasts

Catalog #: CC-7014
AoAF, Aortic Adventitial Fibroblasts
Compare
EA

Product Overview

Human Cardiac-Related Fibroblasts include Aortic Adventitial Fibroblasts (AoAF) isolated from the tunica external of the ascending or descending aorta and cardiac fibroblasts (NHCF-A and -V) isolated from the atrium or ventricle.  Cells are isolated from normal, adult heart tissue. Cryopreserved cells are shipped at passage 2.

CloneticsTM NHCF-V & -A are guaranteed through 5 population doublings and express ≥90% collagen I and ≤10% Von Willibrand factor VIII after thaw. CloneticsTM AoAF are guaranteed through 10 population doublings and are negative for alpha smooth muscle actin. All cells test negative for mycoplasma, bacteria, yeast and fungi. HIV-1, hepatitis B and hepatitis C are not detected for all donors and/or cell lots. A Certificate of Analysis (CoA) is provided for each cell lot purchased.  

 

Applications

  • Vascular diseases
  • Neointimal formation
  • Vascular remodeling
  • Atherosclerosis
  • Hypertension
  • Myocardial repair
  • Extracellular maintenance during cardiac cell / tissue growth
  • Cardiac Fibrosis Paracrine signalling
  • Toxicology
  • Gene expression

Content & Storage

Content

1 x Cryopreserved Ampule with ≥500,000 cells/vial

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Interested in our Webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Need a Quote or Any Support?

Are Lonza's primary cells and media applicable to your project? Do you need a quote or any help? Contact us and a local representative will get back to you.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok